Chiquita Brooks-LaSure, CMS administrator (Chip Somodevilla/Getty Images)
US responds to drugmakers' IRA counteroffers as Medicare price negotiations continue
CMS wants further discussions with pharma companies that are participating in IRA price negotiations, HHS announced on Tuesday.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
